Skip Navigation


ToxSci Advance Access originally published online on June 23, 2005
Toxicological Sciences 2005 87(1):11-14; doi:10.1093/toxsci/kfi240
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
87/1/11    most recent
kfi240v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Maurissen, J. P.
Right arrow Articles by Barrow, C. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maurissen, J. P.
Right arrow Articles by Barrow, C. S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For Permissions, please email: journals.permissions@oupjournals.org

FORUM

Workshop Proceedings: Managing Conflict of Interest in Science. A Little Consensus and A Lot of Controversy

Jacques P. Maurissen*,1, Steven G. Gilbert{dagger}, Miriam Sander{ddagger}, Tom L. Beauchamp§, Shelley Johnson, Bernard A. Schwetz||, Merrill Goozner||| and Craig S. Barrow||||

* The Dow Chemical Company, TERC, Midland, Michigan; {dagger} Institute of Neurotoxicology and Neurological Disorders, Seattle, Washington; {ddagger} Page One Editorial Services, Boulder, Colorado; § Georgetown University, Kennedy Institute of Ethics, Washington, District of Columbia; Oxford University Press, Bethesda, Maryland; || Department of Health and Human Services, Office of Human Research Protection, Rockville, Maryland; ||| Center for Science in the Public Interest, Washington, District of Columbia; |||| The Dow Chemical Company, TERC, Washington, District of Columbia

Received May 5, 2005; accepted June 20, 2005

There is no doubt that participants in the Conflict of Interest (COI) Workshop at the Society of Toxicology (SOT) 2005 Annual Meeting (New Orleans, 6–10 March 2005) engaged in a vigorous and useful exchange of diverse ideas and viewpoints. While there was consensus on the value and interest of this Workshop, there was less consensus and more controversy over many of the issues discussed during the Workshop, which included the distinction between bias and conflict, the success or failure of policies of disclosure, whether waivers should or should not be granted to conflicted individuals in order to seat a "balanced" committee with appropriate expertise, whether conflicted individuals retain the ability to recognize their own conflict, and more. The discussion left no doubt, however, that conflict of interest will remain an important and controversial issue in the scientific community for some time to come.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Toxicol Ind HealthHome page
L. Claxton
A review of conflict of interest, competing interest, and bias for toxicologists
Toxicology and Industrial Health, November 1, 2007; 23(10): 557 - 571.
[Abstract] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.